Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ASND compared with PCVX: revenue, margins and what each company keeps, and the suppliers and customers both name
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
PCVX
Vaxcyte, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ASND
Ascendis Pharma A/S
vs
PCVX
Vaxcyte, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ASND
No earnings history for ASND.
PCVX
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±10.2%
▼
−5.72%
×0.56
Q2 FY26
±8.6%
▲
+5.31%
×0.62
May 7 '26
±7.2%
▼
−9.84%
×1.36
Q1 FY26
±10.5%
▲
+2.75%
×0.27
= implied
ASND realized, solid
PCVX realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
ASND
Ascendis Pharma A/S
Change
256.94
▲
+1.38%
· post 256.91
Mkt cap
$15.9B
PCVX
Vaxcyte, Inc.
Change
63.89
▲
+3.18%
· post 63.88
Closed
Nov 6 '26
Mkt cap
$10.1B
vs
Compare
Closed
Nov 6 '26
ASND
Ascendis Pharma A/S
vs
PCVX
Vaxcyte, Inc.
256.94
▲
+1.38%
post 256.91
Price
63.89
▲
+3.18%
post 63.88
$15.9B
Mkt cap
$10.1B
Change
Change
ASND
256.94
▲
+1.38%
vs
PCVX
63.89
▲
+3.18%
Closed
Nov 6 '26